GB9318912D0 - Humanised antibodies - Google Patents

Humanised antibodies

Info

Publication number
GB9318912D0
GB9318912D0 GB939318912A GB9318912A GB9318912D0 GB 9318912 D0 GB9318912 D0 GB 9318912D0 GB 939318912 A GB939318912 A GB 939318912A GB 9318912 A GB9318912 A GB 9318912A GB 9318912 D0 GB9318912 D0 GB 9318912D0
Authority
GB
United Kingdom
Prior art keywords
humanised antibodies
humanised
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB939318912A
Other versions
GB2268745B (en
GB2268745A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928874A external-priority patent/GB8928874D0/en
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Priority to GB9318912A priority Critical patent/GB2268745B/en
Publication of GB9318912D0 publication Critical patent/GB9318912D0/en
Publication of GB2268745A publication Critical patent/GB2268745A/en
Application granted granted Critical
Publication of GB2268745B publication Critical patent/GB2268745B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • C07K16/465—Igs containing CDR-residues from one specie grafted between FR-residues from another with additional modified FR-residues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GB9318912A 1989-12-21 1993-09-13 Heavy and light chains having a variable domain comprising acceptor framework residues and donor antigen binding residues Expired - Lifetime GB2268745B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9318912A GB2268745B (en) 1989-12-21 1993-09-13 Heavy and light chains having a variable domain comprising acceptor framework residues and donor antigen binding residues

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898928874A GB8928874D0 (en) 1989-12-21 1989-12-21 Humanised antibodies
GB9117612A GB2246570B (en) 1989-12-21 1991-08-15 Antibody molecules having a variable domain comprising acceptor framework residues and donor antigen binding residues
GB9318912A GB2268745B (en) 1989-12-21 1993-09-13 Heavy and light chains having a variable domain comprising acceptor framework residues and donor antigen binding residues

Publications (3)

Publication Number Publication Date
GB9318912D0 true GB9318912D0 (en) 1993-10-27
GB2268745A GB2268745A (en) 1994-01-19
GB2268745B GB2268745B (en) 1994-05-11

Family

ID=26296405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9318912A Expired - Lifetime GB2268745B (en) 1989-12-21 1993-09-13 Heavy and light chains having a variable domain comprising acceptor framework residues and donor antigen binding residues

Country Status (1)

Country Link
GB (1) GB2268745B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins

Also Published As

Publication number Publication date
GB2268745B (en) 1994-05-11
GB2268745A (en) 1994-01-19

Similar Documents

Publication Publication Date Title
GB8905669D0 (en) Modified antibodies
GB8608068D0 (en) Monoclonal antibodies
IL90017A0 (en) Monoclonal antibodies
GB8624899D0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
GB8621910D0 (en) Monoclonal antibodies
ZA898499B (en) Anti-fucosylcermiade monoclonal antibody
GB8715347D0 (en) Monoclonal antibodies
GB8813527D0 (en) Bispecific antibodies
GB8616174D0 (en) Monoclonal antibodies
ZA89258B (en) Monoclonal antibodies
GB8927389D0 (en) Monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
GB9318912D0 (en) Humanised antibodies
GB8610202D0 (en) Monoclonal antibodies
GB8610203D0 (en) Monoclonal antibodies
GB8812137D0 (en) Antibodies
EP0336441A3 (en) Anti-cpbii monoclonal antibody
IE892557L (en) Monoclonal antibodies
IE891298L (en) Monoclonal antibodies
IE890064L (en) Monoclonal antibodies
IE892311L (en) Improved monoclonal antibodies
IE893593L (en) Anti-fucosylcermiade monoclonal antibody
GB8820035D0 (en) Monoclonal antibodies
GB8812962D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
773H Revocation action is not pursued (sect. 73(2)/1977)
PE20 Patent expired after termination of 20 years

Expiry date: 20101220